Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma

Clinical trial NCT02242097 · COMPLETED

Trial details

NCT number: NCT02242097
Sponsor: Northwestern University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Contiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Stage I Mantle Cell Lymphoma Stage III Mantle Cell Lymphoma Stage IV Mantle Cell Lymphoma

Start date: 2015-01-12
Primary completion: 2021-12-07
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.